Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Rituximab Yielded a Significantly Longer Response Compared to Placebo in Steroid Free Population - a Post Hoc Analysis of the Ritp Study

Waleed Ghanima, MD PhD, Marc Michel, Abderrahim Khelif, Bernadette Darne, Pal André Holme, PhDMD

Blood (2019) 134 (Supplement_1): 2358.

https://doi.org/10.1182/blood-2019-126975

Published: 2019

Journal Articles

Safety and Efficacy of the Off-Label Use of Thrombopoietin Receptor Agonists for Immune Thrombocytopenia in Pregnancy: Results from a Multicentre Observational Study

Marc Michel, Marco Ruggeri, Tomás José González-López, MD, Stephane Cheze, MD, Waleed Ghanima, MD PhD, Tor Henrik Anderson Tvedt, Mikael Ebbo, MD PhD, James B. Bussel, MD, Bertrand Godeau, MD

Blood (2019) 134 (Supplement_1): 1081.

https://doi.org/10.1182/blood-2019-122595

Published: 2019

Journal Articles

The Risk of Thromboembolism Associated with Treatment of ITP with Rituximab: Adverse Event Reported in Two Randomized Controlled Trials

Lamya Garabet, Pal André Holme, PhDMD, Bernadette Darne, Abderrahim Khelif, Tor Henrik Anderson Tvedt, MD, Marc Michel, Waleed Ghanima, MD PhD

Blood (2019) 134 (Supplement_1): 4892.

https://doi.org/10.1182/blood-2019-126974

Published: 2019

Journal Articles

The Psychometric Properties of the ITP Life Quality Index Assessed in a Large Multinational "Real-World" Cohort of Immune Thrombocytopaenia Patients

Philip Griffiths, Laura Grant, Nicola Bonner, MSc, Denise D'Alessio, MBA, Quentin A. Hill, Drew Provan, MD, Waleed Ghanima, MD PhD, Nichola Cooper, MD MRCP, Ricardo Viana, PhD

Blood (2019) 134 (Supplement_1): 386.

https://doi.org/10.1182/blood-2019-125766

Published: 2019

Journal Articles

Physicians' and Patients' Perspectives on Treatments in ITP - a Multi-Country Perspective: Results from the ITP World Impact Survey (I-WISh)

James B. Bussel, MD, Waleed Ghanima, MD PhD, Yoshiaki Tomiyama, MD, Donald M. Arnold, MD, Drew Provan, MD, Ming Hou, MD PhD, Cristina Santoro, MD PhD, Serge Laborde, Alexandra Kruse, Caroline Kruse, Mervyn Morgan, Barbara Lovrencic, John Waller, PhD, Jens Haenig, Nichola Cooper, MD MRCP

Blood (2019) 134 (Supplement_1): 1097.

https://doi.org/10.1182/blood-2019-130591

Published: 2019

Journal Articles

Enhanced Responses to Fostamatinib As Second-Line Therapy and in Persistent Immune Thrombocytopenia (ITP) Patients

Ralph Boccia, MD, Michael A. Boxer, MD, Waleed Ghanima, MD PhD, Quentin A. Hill, Michelle Sholzberg, MDBSc,FRCPC,MSc, Michael D. Tarantino, MD, Yuliya Kreychman, PharmD, Robert P. Numerof, PhD, Brian Olender, BA, Leslie Todd, Sandy Tong, MD, Anne-Marie Duliege, MDMS, Nichola Cooper, MD MRCP, James B. Bussel, MD

Blood (2019) 134 (Supplement_1): 1069.

https://doi.org/10.1182/blood-2019-126473

Published: 2019

Journal Articles

Long Term Remission Achieved By Fostamatinib in ITP: A Case Report

Waleed Ghanima, MD PhD, Tjønnfjord Eirik, MD PhD

Blood (2019) 134 (Supplement_1): 4901.

https://doi.org/10.1182/blood-2019-128359

Published: 2019

Journal Articles

Thrombin-Generating Capacity of Microvesicles (MVs) in Patients with Immune Thrombocytopenia (ITP) before and during Treatment with Thrombopoietin-Receptor Agonists (TPO-RA)

Lamya Garabet, Waleed Ghanima, MD PhD, Marit Hellum, Per Morten Sandset, James B. Bussel, MD, Carola E. Henriksson

Blood (2018) 132 (Supplement 1): 2511.

https://doi.org/10.1182/blood-2018-99-116911

Published: 2018

Journal Articles

Romiplostim Treatment Pattern of Adult Chronic Immune Thrombocytopenia in Routine Clinical Care in Three Nordic Countries

Mette Nørgaard, Nickolaj Risbo Kristensen, Henrik Frederiksen, MD PhD, Shahram Bahmanyar, Waleed Ghanima, MD PhD, Naufil Alam, Anne Gulbech Ording, Henrik Toft Sørensen, Christian Fynbo Christiansen

Blood (2018) 132 (Supplement 1): 4998.

https://doi.org/10.1182/blood-2018-99-110965

Published: 2018

Journal Articles

Long-Term Maintenance of Platelet Responses in Adult Patients with Persistent/Chronic Immune Thrombocytopenia Treated with Fostamatinib: 1-Year Efficacy and Safety Results

James B. Bussel, MD, Donald M Arnold, MD, Nichola Cooper, MA, MD MRCP, FRCPath, Alhossain A Khalafallah, MD, Michael Boxer, MD, Darla Liles, MD, Waleed Ghanima, MD PhD, Keith McCrae, MD, Hany Zayed, Benoit Cadieux, PhD, Anne-Marie Duliege, MDMS

Blood (2017) 130 (Supplement 1): 16.

https://doi.org/10.1182/blood.V130.Suppl_1.16.16

Published: 2017

Journal Articles

A Nordic Population-Based Cohort Study of Risk of Arterial Thrombotic and Venous Thromboembolic Events in Patients with Primary Chronic Immune Thrombocytopenia (cITP)

Christian F Christiansen, MD PhD, Karynsa Cetin, M.P.H, Merete Lund Mægbæk, MSc, Waleed Ghanima, MD PhD, Shahram Bahmanyar, MD PhD, Scott Stryker, MD DrPH, Mette Nørgaard, MD PhD

Blood (2014) 124 (21): 4845.

https://doi.org/10.1182/blood.V124.21.4845.4845

Published: 2014

Journal Articles

Bone Marrow Fibrosis In Immune Thrombocytopenia (ITP) Patients Treated With Thrombopoietin Receptor Agonists (TRA) – a Single Center Long-Term Follow-Up

Waleed Ghanima, MD, PhD, Julia Turbiner Geyer, MD, Christina Soo Lee, BA, Attilio Orazi, MD, Leonardo Boiocchi, MD, Allison Imahiyerobo, James B. Bussel, MD

Blood (2013) 122 (21): 3527.

https://doi.org/10.1182/blood.V122.21.3527.3527

Published: 2013

Journal Articles

Rituximab Combined With Three Cycles Of High Dose Dexamethasone Provides a Long Term Response Rate Similar To That Of Splenectomy In Patients With Immune Thrombocytopenia (ITP) Of Duration Less Than 2 Years

Christina S Lee, B.A., Allison Imahiyerobo, ANP-BC, Micha Thompson, B.A., Marina Izak Karaev, M.D., Waleed Ghanima, MD, PhD, James B Bussel, MD

Blood (2013) 122 (21): 2310.

https://doi.org/10.1182/blood.V122.21.2310.2310

Published: 2013

Journal Articles

Rituximab As Second Line Treatment For Adult Immune Thrombocytopenia (ITP): A Multicentre, Randomized, Double Blind, Placebo-Controlled Study – The Ritp Study (NCT00344149)

Waleed Ghanima, MD, PhD, Abderrahim Khelif, Neila Benromdhan, MD, Anders Waage, MD, PhD, Geir E. Tjonnfjord, MD, PhD, Marc Michel, Darne Bernadette, MD, Johannes Kahrs, MD, Pål Andre Holme, MD, PhD

Blood (2013) 122 (21): 449.

https://doi.org/10.1182/blood.V122.21.449.449

Published: 2013

Journal Articles

Rituximab Combined with 3 Cycles of High Dose Dexamethasone Improves Response in Patients with Newly-Diagnosed, Persistent, and Chronic Immune Thrombocytopenia (ITP)

Rebecca L. Elstrom, MD, Caroline Seery, BA, Christina Moll, Allison Miller, NP, Julia Gabor, Daniel Maffezzoli, Paul Andrew Basciano, MD, Waleed Ghanima, MD, James B Bussel, MD

Blood (2012) 120 (21): 3345.

https://doi.org/10.1182/blood.V120.21.3345.3345

Published: 2012

Journal Articles

Improved Functional Outcome After Additional Catheter-Directed Thrombolysis for Acute Iliofemoral Deep Vein Thrombosis: Results of a Randomized Controlled Clinical Trial (The CaVenT Study)

Tone Rønnaug Enden, MD, PhD, Ylva Haig, MD, Nils-Einar Kløw, MD, PhD, Carl Erik Slagsvold, MD, PhD, Leiv Sandvik, PhD, Waleed Ghanima, MD, PhD, Geir Hafsahl, MD, PhD, Pål Andre Holme, MD, PhD, Lars Olaf Holmen, MD, Anne Mette Njaastad, MD, Gunnar Sandbaek, MD, PhD, Per Morten Sandset, MD, PhD

Blood (2011) 118 (21): LBA-1.

https://doi.org/10.1182/blood.V118.21.LBA-1.LBA-1

Published: 2011

Journal Articles

A Fast Track Strategy for Managing Suspected Pulmonary Embolism (PE) in Outpatients.

Waleed Ghanima, MD, Vibeke Almaas, MD, Saad Aballi, MD, Dorje Christina, MD, Per Morten Sandset, MD, PhD

Blood (2004) 104 (11): 1766.

https://doi.org/10.1182/blood.V104.11.1766.1766

Published: 2004

NARROW

Rituximab Yielded a Significantly Longer Response Compared to Placebo in Steroid Free Population - a Post Hoc Analysis of the Ritp Study

Safety and Efficacy of the Off-Label Use of Thrombopoietin Receptor Agonists for Immune Thrombocytopenia in Pregnancy: Results from a Multicentre Observational Study

The Risk of Thromboembolism Associated with Treatment of ITP with Rituximab: Adverse Event Reported in Two Randomized Controlled Trials

The Psychometric Properties of the ITP Life Quality Index Assessed in a Large Multinational "Real-World" Cohort of Immune Thrombocytopaenia Patients

Physicians' and Patients' Perspectives on Treatments in ITP - a Multi-Country Perspective: Results from the ITP World Impact Survey (I-WISh)

Enhanced Responses to Fostamatinib As Second-Line Therapy and in Persistent Immune Thrombocytopenia (ITP) Patients

Long Term Remission Achieved By Fostamatinib in ITP: A Case Report

Thrombin-Generating Capacity of Microvesicles (MVs) in Patients with Immune Thrombocytopenia (ITP) before and during Treatment with Thrombopoietin-Receptor Agonists (TPO-RA)

Romiplostim Treatment Pattern of Adult Chronic Immune Thrombocytopenia in Routine Clinical Care in Three Nordic Countries

Long-Term Maintenance of Platelet Responses in Adult Patients with Persistent/Chronic Immune Thrombocytopenia Treated with Fostamatinib: 1-Year Efficacy and Safety Results

A Nordic Population-Based Cohort Study of Risk of Arterial Thrombotic and Venous Thromboembolic Events in Patients with Primary Chronic Immune Thrombocytopenia (cITP)

Bone Marrow Fibrosis In Immune Thrombocytopenia (ITP) Patients Treated With Thrombopoietin Receptor Agonists (TRA) – a Single Center Long-Term Follow-Up

Rituximab Combined With Three Cycles Of High Dose Dexamethasone Provides a Long Term Response Rate Similar To That Of Splenectomy In Patients With Immune Thrombocytopenia (ITP) Of Duration Less Than 2 Years

Rituximab As Second Line Treatment For Adult Immune Thrombocytopenia (ITP): A Multicentre, Randomized, Double Blind, Placebo-Controlled Study – The Ritp Study (NCT00344149)

Rituximab Combined with 3 Cycles of High Dose Dexamethasone Improves Response in Patients with Newly-Diagnosed, Persistent, and Chronic Immune Thrombocytopenia (ITP)

Improved Functional Outcome After Additional Catheter-Directed Thrombolysis for Acute Iliofemoral Deep Vein Thrombosis: Results of a Randomized Controlled Clinical Trial (The CaVenT Study)

A Fast Track Strategy for Managing Suspected Pulmonary Embolism (PE) in Outpatients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only